Zurich, Switzerland

Steve Pascolo

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 1.9

ph-index = 14

Forward Citations = 616(Granted Patents)


Location History:

  • Tübingen, DE (2016 - 2019)
  • Zürich, CH (2020 - 2021)
  • Tubingen, DE (2012 - 2022)
  • Zurich, CH (2017 - 2023)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
Loading Chart...
24 patents (USPTO):Explore Patents

Title: Steve Pascolo: Innovator in RNA Technology

Introduction

Steve Pascolo is a notable inventor based in Zurich, Switzerland, recognized for his significant contributions to the field of RNA technology. With 23 patents to his name, Pascolo’s work primarily focuses on methods related to RNA production and its applications in healthcare.

Latest Patents

Among his latest patents is a groundbreaking invention related to a method for producing RNA. This method is designed to be scalable and aims to provide RNA at high purity levels while adhering to GMP and cGMP-compliant conditions. It includes specific processes for quality control in the manufacturing of template DNA and in the method for producing RNA, particularly through in vitro transcription. Another significant patent focuses on RNA-coded antibodies, describing the use of non-modified or modified RNA for the expression of such antibodies. This innovation has potential applications in developing pharmaceutical compositions, including passive vaccines for the treatment of various diseases such as tumors, cancer, cardiovascular issues, infectious diseases, autoimmune disorders, viral diseases, and even in gene therapy.

Career Highlights

Steve Pascolo has had a distinguished career, having worked with prominent companies such as CureVac AG and BioNTech AG. His expertise in RNA technology has positioned him as a leader in the industry, contributing to advancements that have the potential to revolutionize medical treatment.

Collaborations

Throughout his career, Pascolo has collaborated with several notable individuals, including Florian Von Der Mülbe and Ingmar Hoerr. These partnerships have fostered innovation and the development of new technologies that push the boundaries of current scientific understanding.

Conclusion

In conclusion, Steve Pascolo's contributions to RNA technology reflect his commitment to advancing medical science. His inventions and collaborations continue to pave the way for new treatments and therapies, underscoring the importance of innovation in the field of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…